Immunotherapy drugs are often referred to as “checkpoint inhibitors”, and they can assist with the symptoms that are often associated with melanoma, as well as provide a better quality of life during treatment and a better prognosis for the patient’s overall lifespan. These drugs and medications include: pembrolizumab (also known as Keytruda), nivolumab (also known as Opdivo) and also ipilimumab (also known as Yervoy). These medications can often have very serious side effects, and the patients using immunotherapy drugs must be closely monitored.

This site offers information designed for educational purposes only. You should not rely on any information on this site as a substitute for professional medical advice, diagnosis, treatment, or as a substitute for, professional counseling care, advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other healthcare professional.